Marit Vermunt

From 2013 to 2015, I worked as an MD in the AVL and after this, I started as a PhD student. My work focuses on clinical trials with novel oral taxane formulations that are co-administrated with ritonavir, in patients with prostate cancer and other types of solid tumors.